Diabetes and Alzheimer's Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?

Area of Science:

• Neuroscience
• Endocrinology
• Metabolic Disorders

Background:

• Growing evidence links type 2 diabetes mellitus (T2DM) to increased Alzheimer's disease (AD) risk.
• AD is sometimes termed 'type 3 diabetes' (T3D), highlighting the role of insulin signaling.
• T2DM-associated metabolic disturbances contribute to brain insulin resistance and neurodegeneration.

Purpose of the Study:

• To review the molecular mechanisms connecting T2DM-induced insulin signaling dysregulation to AD pathogenesis.
• To analyze the role of oxidative stress, reactive oxygen species (ROS), and mitochondrial dysfunction.
• To discuss potential therapeutic strategies for oxidative stress damage in T2DM and AD.

Main Methods:

• Literature review of clinical and epidemiological studies.
• Analysis of molecular mechanisms linking T2DM and AD.
• Discussion of oxidative stress and mitochondrial function in neurodegeneration.

Main Results:

• T2DM causes neuronal insulin resistance, promoting amyloid beta (Aβ) deposition and Tau protein impairment.
• Hyperglycemia, hyperinsulinemia, and inflammation in T2DM exacerbate Aβ accumulation.
• Oxidative damage and mitochondrial dysfunction in T2DM patients correlate with cognitive decline, mirroring AD pathology.

Conclusions:

• Insulin signaling dysregulation in T2DM is a key factor in AD pathogenesis.
• Oxidative stress and mitochondrial impairment are shared pathways in T2DM and AD.
• Therapies targeting oxidative stress may offer preventive or treatment benefits for both conditions.